Philipp Schulte-Noelle is an experienced manager with deep knowledge in healthcare. Until recently, he served as CEO of Ottobock SE & Co. KGaA, the world’s leading bionic healthtech player in the fields of prosthetics, neuroorthotics & exoskeletons.
Prior to this, he worked at health care company Fresenius SE & Co. KGaA as Head of Corporate Business Development/M&A and Fresenius Kabi AG as CFO. Before joining the healthcare industry, he worked at private equity firm Permira and Goldman Sachs.
Philipp Schulte-Noelle holds a degree in business law from the University of Bayreuth and an MBA from INSEAD.